EASD 2021: Investigational Combination of Pramlintide and Prandial Insulin Shows Promise in Type 1 Diabetes
Benefits include improved glycemic control, reduced dose of prandial insulin, and weight loss
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.